# Tempest Therapeutics, Inc.: Form DEF 14A, filed May 2, 2022

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: DEF 14A
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 16:05 ET
- Period: 2022-06-17
- Accession: 0001193125-22-136738
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312522136738/d342375ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312522136738/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312522136738/d342375ddef14a.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-136738. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
